Charlotte Allerton, Head of Discovery and Early Development at Pfizer joins Paul Biondi, Flagship Executive Partner and President of Pioneering Medicines, for a discussion about pioneering partnerships that leverage capabilities from across the biopharma industry to develop potentially transformational therapeutics, including the strategic alliance between Pfizer and Flagship Pioneering.
        More from:
                    Human Health
            
    
    
 
                        What If We Could See Disease Coming and Stop It?
 
                        Amanda Kay on a New Approach to Biopharma Partnerships
 
                        Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK
 
                        Pioneering Partnerships: Accelerating our Collaboration with Pfizer
 
                        Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies
